Skip to main content

BioCardia, Inc.

BCDA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000925741

In the last 90 days, BioCardia, Inc. insiders filed 9 open-market purchases and 0 sales; 21 institutions reported holding it in 13F filings for Q2 2026, worth $1.65M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by BioCardia, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
9 filings
1 insider, $30.1K in total
Open-market sells
0 filings
Insiders trading
1
Net value
+$30.1K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for BioCardia, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for BioCardia, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Altman PeterPresident and CEO383,885Sep 23, 202623
Stertzer Simon HDirector166,338Jul 7, 20263
Slosman MarvinDirector–Jul 7, 20262
McClung DavidChief Financial Officer114,245Jul 7, 20263
Gillis Edward MSenior Vice President, Devices54,126Jul 7, 20263
Blank Andrew ScottDirector634,023IndirectJul 7, 20262
Allen Jim L.Director109,661Jul 7, 20262
Moyes Jay MDirector–Jul 7, 20262
Facteau BillDirector13,123Jul 7, 20262
Krasno Richard MDirector16,268Apr 28, 20250
Frost Phillip MD Et Al10% Owner1,896,025IndirectJan 22, 20240
Frost Gamma Investments Trust10% Owner1,896,025IndirectJan 22, 20240
Zsebo Krisztina MDirector–May 12, 20230

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 18, 2021 (view filing)Aug 171 dayAltman PeterPresident and CEOPPurchase+3.50K$2.94+$10.3K+1.5%232.9K after
Nov 18, 2021 (view filing)Nov 18Same dayAltman PeterPresident and CEOPPurchase+5.00K$2.20+$11.0K+2.1%237.9K after
Apr 18, 2022 (view filing)Apr 18Same dayAltman PeterPresident and CEOPPurchase+13.5K$1.39+$18.8K+4.3%328.1K after
May 2, 2022 (view filing)Apr 28-294 daysAltman PeterPresident and CEOPPurchase+5.00K$1.60+$8.00K+1.5%333.1K after2 lots
May 13, 2022 (view filing)May 11-132 daysAltman PeterPresident and CEOPPurchase+15.0K$1.24+$18.6K+4.5%348.1K afterFrom original3 lots
Jun 13, 2022 (view filing)Jun 103 daysAltman PeterPresident and CEOPPurchase+4.50K$1.46+$6.57K+1.4%321.2K after
Sep 22, 2022 (view filing)Sep 211 dayAltman PeterPresident and CEOPPurchase+2.75K$1.92+$5.28K+0.9%323.9K after
Sep 26, 2022 (view filing)Sep 22-234 daysAltman PeterPresident and CEOPPurchase+4.50K$1.83+$8.23K+1.4%328.4K after2 lots
Oct 11, 2022 (view filing)Oct 101 dayMcClung DavidChief Financial OfficerPPurchase+2.00K$2.07+$4.14K+2.6%78.5K after
Nov 14, 2022 (view filing)Nov 10-114 daysAltman PeterPresident and CEOPPurchase+4.50K$1.87+$8.40K+1.4%332.9K after2 lots
Dec 20, 2022 (view filing)8:15 PM ETDec 164 daysFrost Phillip MD Et Al and 1 other10% OwnerPPurchase+595.2K$1.68+$1.00M+41.6%2.03M after
Apr 14, 2023 (view filing)Jan 11, 2022458 daysLateAltman PeterPresident and CEOPPurchase+100$1.87+$1870.0%353.7K after
May 30, 2023 (view filing)May 264 daysAltman PeterPresident and CEOPPurchase+6.20K$1.60+$9.92K+1.3%469.2K after
Aug 18, 2023 (view filing)Aug 144 daysAltman PeterPresident and CEOPPurchase+4.50K$0.88+$3.96K+1.0%443.3K afterAmended
Aug 18, 2023 (view filing)Aug 171 dayAltman PeterPresident and CEOPPurchase+4.00K$0.87+$3.48K+0.9%447.3K afterAmended
Jan 22, 2024 (view filing)8:38 PM ETJan 193 daysFrost Phillip MD Et Al and 1 other10% OwnerSSale−129.8K$0.43−$55.8K−6.4%1.90M after
Feb 15, 2024 (view filing)7:00 AM ETFeb 132 daysAltman PeterPresident and CEOPPurchase+108.1K$0.4625+$50.0K+24.2%555.4K after
Feb 15, 2024 (view filing)7:00 AM ETFeb 132 daysAltman PeterPresident and CEOPPurchase+54.1K–––121.5K afterDerivative
Mar 28, 2024 (view filing)7:33 PM ETMar 28Same dayAltman PeterPresident and CEOPPurchase+500$0.39+$195+0.1%555.9K after
Apr 19, 2024 (view filing)5:38 PM ETApr 19Same dayAltman PeterPresident and CEOPPurchase+2.75K$0.3683+$1.01K+0.5%558.7K after
Jun 12, 2024 (view filing)Jun 102 daysAltman PeterPresident and CEOPPurchase+1.00K$3.36+$3.36K+2.7%38.2K after
Jun 17, 2024 (view filing)Jun 143 daysAltman PeterPresident and CEOPPurchase+500$3.52+$1.76K+1.3%38.7K after
Jun 24, 2024 (view filing)Jun 213 daysAltman PeterPresident and CEOPPurchase+500$3.29+$1.65K+1.3%39.2K after
Jul 2, 2024 (view filing)Jun 28-Jul 14 daysAltman PeterPresident and CEOPPurchase+500$3.03+$1.51K+1.3%39.7K after2 lots
Nov 19, 2024 (view filing)Nov 154 daysAltman PeterPresident and CEOPPurchase+1.35K$1.87+$2.52K+1.3%105.3K after
Dec 9, 2024 (view filing)Dec 54 daysAltman PeterPresident and CEOPPurchase+250$2.22+$555+0.2%105.6K after
Dec 26, 2024 (view filing)Dec 206 daysGillis Edward MSenior Vice President, DevicesSSale−3.26K$2.00−$6.51K−26.6%8.97K after
Dec 26, 2024 (view filing)Dec 233 daysAltman PeterPresident and CEOPPurchase+1.00K$2.06+$2.06K+0.9%106.6K after
Jan 30, 2025 (view filing)Jan 29-301 dayAltman PeterPresident and CEOPPurchase+739$2.39+$1.77K+0.7%107.3K after2 lots
Feb 11, 2025 (view filing)Feb 74 daysAltman PeterPresident and CEOPPurchase+600$2.48+$1.49K+0.6%107.9K after
Mar 4, 2025 (view filing)Mar 31 dayAltman PeterPresident and CEOPPurchase+500$2.11+$1.05K+0.5%108.4K after
Mar 5, 2025 (view filing)Mar 3-42 daysStertzer Simon HDirectorPPurchase+38.3K$2.30+$88.1K+214.5%56.1K after2 lots
Mar 7, 2025 (view filing)Mar 52 daysStertzer Simon HDirectorPPurchase+1.00K$2.45+$2.45K+1.8%57.1K after
Apr 3, 2025 (view filing)Apr 3Same dayAltman PeterPresident and CEOPPurchase+1.20K$2.24+$2.69K+1.1%109.6K after
Apr 4, 2025 (view filing)Apr 2-32 daysAltman PeterPresident and CEOPPurchase+1.10K$2.21+$2.44K+1.0%110.7K after2 lots
Apr 7, 2025 (view filing)Apr 43 daysAltman PeterPresident and CEOPPurchase+800$2.04+$1.63K+0.7%111.5K after
Apr 8, 2025 (view filing)Apr 71 dayAltman PeterPresident and CEOPPurchase+500$1.96+$980+0.4%112.0K after
Apr 14, 2025 (view filing)Apr 10-114 daysAltman PeterPresident and CEOPPurchase+600$2.01+$1.21K+0.5%112.6K after2 lots
Apr 17, 2025 (view filing)Apr 152 daysAltman PeterPresident and CEOPPurchase+100$2.14+$214+0.1%112.7K after
Apr 25, 2025 (view filing)Apr 232 daysAltman PeterPresident and CEOPPurchase+26.2K$1.91+$50.1K+23.3%139.0K after
Apr 25, 2025 (view filing)Apr 232 daysAltman PeterPresident and CEOPPurchase+26.2K–––71.5K afterDerivative
Apr 25, 2025 (view filing)Apr 232 daysStertzer Simon HDirectorPPurchase+105.0K$1.91+$200.5K+682.7%120.4K after
Apr 25, 2025 (view filing)Apr 232 daysStertzer Simon HDirectorPPurchase+105.0K–––105.0K afterDerivative
Apr 25, 2025 (view filing)Apr 232 daysBlank Andrew ScottDirectorPPurchase+131.2K$1.91+$250.7K+97.4%266.0K after
Apr 25, 2025 (view filing)Apr 232 daysBlank Andrew ScottDirectorPPurchase+131.2K–––242.2K afterDerivative
Apr 25, 2025 (view filing)Apr 232 daysFacteau BillDirectorPPurchase+13.1K$1.91+$25.1KNew position13.1K after
Apr 25, 2025 (view filing)Apr 232 daysFacteau BillDirectorPPurchase+13.1K–––13.1K afterDerivative
Apr 25, 2025 (view filing)Apr 232 daysMcClung DavidChief Financial OfficerPPurchase+13.1K$1.91+$25.1K+43.7%43.1K after
Apr 25, 2025 (view filing)Apr 232 daysMcClung DavidChief Financial OfficerPPurchase+13.1K–––21.5K afterDerivative
Apr 28, 2025 (view filing)Apr 235 daysLateKrasno Richard MDirectorPPurchase+13.1K$1.91+$25.1K+417.3%16.3K after